发明名称 |
FORMULATIONS OF INDOLE-3-CARBINOL DERIVED ANTITUMOR AGENTS WITH INCREASED ORAL BIOAVAILABILITY |
摘要 |
A pharmaceutical composition for treating, inhibiting, or preventing cancer can include an indole-3-carbinol derivative compound in a pharmaceutically acceptable carrier that is configured for oral administration. The indole-3-carbinol derivative compound can have antitumor activity, and oral administration can provide blood bioavailability of about 0.5% to about 25%. The pharmaceutically acceptable carrier can include a hydroxyl-fatty acid PEG monoester and/or diester. The carrier can be a hydroxyl-fatty acid PEG ester that includes 12-hydroxy stearate. The carrier can be a hydroxyl-fatty acid PEG ester that includes a PEG having from about 100 MW to about 200,000 MW. The indole-3- carbinol derivative can be 2,10-dicarbethoxy-6-methoxy-5,7-dihydro-indolo-(2,3- b)carbazole. |
申请公布号 |
WO2010118339(A3) |
申请公布日期 |
2011.02.17 |
申请号 |
WO2010US30565 |
申请日期 |
2010.04.09 |
申请人 |
UNIVERSITY OF KANSAS;RAWJEWSKI, ROGER, A.;HASLAM, JOHN, L. |
发明人 |
RAWJEWSKI, ROGER, A.;HASLAM, JOHN, L. |
分类号 |
A61K9/14;A61K9/06;A61K9/20;A61K31/404;A61K47/34;A61P35/00 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|